Partners

Daiichi Sankyo

Daiichi Sankyo is a global biopharmaceutical company headquartered in Japan. The company focuses on the development of innovative medicines, with a strong emphasis on oncology, cardiovascular diseases and other serious illnesses. With research and operations in more than 20 countries, Daiichi Sankyo aims to save lives and improve quality of life through breakthrough therapies.

Our compassion for patients goes beyond the drugs we develop. Cancer affects each person differently, with consequences beyond the disease itself. At Daiichi Sankyo, we believe that everyone living with cancer is an expert in his or her own experience. That's why we prioritize patients' needs and perspectives in everything we do - from research and clinical trials to the way we communicate.

Our goal is to make innovative therapies available to every patient as quickly as possible so they can benefit. We are proud to support patient organizations like Pink Ribbon because we know that amplifying the patient's voice contributes to better care. Across Europe, we work with more than 40 patient advocacy organizations to:

  • Develop meaningful patient information and materials
  • Gather insights through advisory boards and experiential data
  • Promote diversity and inclusion in clinical research
  • To ensure that patients help shape our studies and care pathways

About Daiichi Sankyo

Daiichi Sankyo is a global innovative healthcare organization with more than 120 years of experience. We discover, develop and deliver new standards of care to improve the quality of life for individuals with cancer, cardiovascular disease and other serious conditions. Our mission is to contribute to the sustainable development of society through science and innovation.

For more information, please visit our website.

Learn more:
Daiichi Sankyo

Related articles

No articles were found with this project.
View all our articles here.
How can you help?